Skip to main content

Davis Polk & Wardwell and Zhong Lun Law Firm advised Chinese biopharmaceutical company Antengene Corporation on its $335 million IPO in Hong Kong, with Herbert Smith Freehills and Commerce & Finance Law Offices advising the joint sponsors and the underwriters.

Antengene is a clinical-stage Asia-Pacific biopharmaceutical company offering R&D capabilities and oncology therapies.

The listing is the latest by a Chinese biopharmaceutical company in Hong Kong, which has seen a flurry of such IPOs. Recent other issuers include Simcere Pharmaceutical Group, JHBP (CY) Holdings and Everest Medicines.

The Herbert Smith Freehills team was led by Matt Emsley and Stanley Xie.

 

To contact the editorial team, please email ALBEditor@thomsonreuters.com. 

Related Articles

Deals

9 firms advise on milestone $8.2 bln cross-border insurance deal

by Sarah Wong |

Global law firms Debevoise & Plimpton, Kirkland & Ellis and Herbert Smith Freehills are acting for Bermuda-based insurer Resolution Life on its $8.2 billion sale to Japan’s Nippon Life Insurance, the largest overseas acquisition by a Japanese insurer to date.

Deals

Top international firms act on landmark $7.1 bln ESR take-private deal

by Nimitt Dixit |

Global law firms Freshfields, Latham & Watkins, Kirkland & Ellis, Paul, Weiss, Rifkind, Wharton & Garrison and Cleary Gottlieb Steen & Hamilton have steered an offer to take the Hong Kong-listed ESR Group private in a deal valued at $7.1 billion.

Deals

Fangda, KWM act on HKAA’s $592 mln acquisition of Zhuhai Airport stake

by Hu Yangxiaoxiao 胡阳潇潇 |

Fangda Partners has advised the Hong Kong Airport Authority (HKAA) on its agreement to purchase a 35 percent stake in Zhuhai Airport for approximately $592 million, with King & Wood Mallesons representing the seller, Zhuhai Transportation.